Skip to main content
Top
Published in: Journal of General Internal Medicine 15/2023

22-06-2023 | Care | Original Research

Paid Care for People with Functional Impairment and Serious Illness: Results from the Health and Retirement Study

Authors: Jennifer M. Reckrey, MD, Hannah Kleijwegt, MS, R. Sean Morrison, MD, Stephanie Nothelle, MD, Amy S. Kelley, MD MSHS, Katherine A. Ornstein, PhD

Published in: Journal of General Internal Medicine | Issue 15/2023

Login to get access

Abstract

Background

Paid caregivers (e.g., home health aides) care for individuals living at home with functional impairment and serious illnesses (health conditions with high risk of mortality that impact function and quality of life).

Objective

To characterize those who receive paid care and identify factors associated with receipt of paid care in the context of serious illness and socioeconomic status.

Design

Retrospective cohort study.

Participants

Community-dwelling participants ≥ 65 years enrolled in the Health and Retirement Study (HRS) between 1998 and 2018 with new-onset functional impairment (e.g., bathing, dressing) and linked fee-for-service Medicare claims (n = 2521).

Main Measures

Dementia was identified using HRS responses and non-dementia serious illness (e.g., advanced cancer, end-stage renal disease) was identified using Medicare claims. Paid care support was identified using HRS survey report of paid help with functional tasks.

Key Results

While about 27% of the sample received paid care, those with both dementia and non-dementia serious illnesses in addition to functional impairment received the most paid care (41.7% received ≥ 40 h of paid care per week). In multivariable models, those with Medicaid were more likely to receive any paid care (p < 0.001), but those in the highest income quartile received more hours of paid care (p = 0.05) when paid care was present. Those with non-dementia serious illness were more likely to receive any paid care (p < 0.001), but those with dementia received more hours of care (p < 0.001) when paid care was present.

Conclusions

Paid caregivers play a significant role in meeting the care needs of those with functional impairment and serious illness and high paid care hours are common among those with dementia in particular. Future work should explore how paid caregivers can collaborate with families and healthcare teams to improve the health and well-being of the seriously ill throughout the income spectrum.
Literature
28.
go back to reference O’Malley Watts M, Musumeci M, Chidambaram P. Medicaid Home and Community-Based Services Enrollment and Spending. Henry J. Kaiser Family Foundation. February 2020 Issue Brief. O’Malley Watts M, Musumeci M, Chidambaram P. Medicaid Home and Community-Based Services Enrollment and Spending. Henry J. Kaiser Family Foundation. February 2020 Issue Brief.
33.
go back to reference Schulz R, Martire LM. Family Caregiving of Persons with Dementia: Prevalence, Health Effects, and Support Strategies. Am J Geriatr Psychiatry. 2004;12(3):240-9.CrossRefPubMed Schulz R, Martire LM. Family Caregiving of Persons with Dementia: Prevalence, Health Effects, and Support Strategies. Am J Geriatr Psychiatry. 2004;12(3):240-9.CrossRefPubMed
Metadata
Title
Paid Care for People with Functional Impairment and Serious Illness: Results from the Health and Retirement Study
Authors
Jennifer M. Reckrey, MD
Hannah Kleijwegt, MS
R. Sean Morrison, MD
Stephanie Nothelle, MD
Amy S. Kelley, MD MSHS
Katherine A. Ornstein, PhD
Publication date
22-06-2023
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 15/2023
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-023-08262-9

Other articles of this Issue 15/2023

Journal of General Internal Medicine 15/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine